Stocks · Korea
307280
KOSDAQ
Wonbiogen
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER6.42x
PBR0.99x
EPS933 KRW
BPS6,072 KRW
ROE16.84%
Dividend yield2.34%
DPS140 KRW
Payout ratio15.01%
Returns and 52-week range
1W-1.48%
1M-2.92%
3M+7.54%
6M-13.94%
1Y+8.12%
YTD-9.79%
52W high8,400원
52W low4,765원
From 52W high-28.69%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 267억 | 52억 | 33억 | 19.3% |
| 2023 | 296억 | 71억 | 60억 | 24.1% |
| 2024 | 304억 | 64억 | 53억 | 21.1% |
| 2025 | 352억 | 79억 | 65억 | 22.5% |
| Quarterly | ||||
| 2024 4Q | 85억 | 15억 | 13억 | 17.6% |
| 2025 1Q | 83억 | 15억 | 13억 | 18.6% |
| 2025 2Q | 84억 | 19억 | 14억 | 22.5% |
| 2025 3Q | 92억 | 24억 | 22억 | 26.0% |
| 2025 4Q | 94억 | 21억 | 15억 | 22.4% |
| 2026 1Q | 93억 | 21억 | 19억 | 22.8% |
Company
Address: 경상북도 구미시 1공단로5길 56 ㈜원바이오젠
Peers in the same sector
Recent filings
- 2026-10-02[기재정정]반기보고서 (2026.06)
- 2026-08-14반기보고서 (2026.06)
- 2026-05-12분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.